Tci Wealth Advisors, Inc. Neurocrine Biosciences Inc Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$94.11 - $123.02 $6,587 - $8,611	-70 Reduced 94.59%	4 $0
Q4 2022 Feb 06, 2023	BUY	$106.72 - $127.06 $7,470 - $8,894	70 Added 1750.0%	74 $8,000
Q2 2022 Jul 19, 2022	SELL	$75.79 - $100.07 $530 - $700	-7 Reduced 63.64%	4 $0
Q1 2022 Apr 29, 2022	BUY	$72.45 - $94.81 $796 - $1,042	11 New	11 $1,000
Q4 2018 Jan 17, 2019	SELL	$68.32 - $124.36 $204 - $373	-3 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$98.88 - $125.85 $889 - $1,132	-9 Reduced 75.0%	3 $0
Q2 2018 Jul 27, 2018	BUY	$75.3 - $105.99 $903 - $1,271	12 New	12 $1,000

638

93.8M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.